APA

Tanaka Y., Takeuchi T., Umehara H., Nanki T., Yasuda N., Tago F., Kawakubo M., Kitahara Y., Hojo S., Kawano T. & Imai T. (20180705). Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. : Modern rheumatology.

Chicago

Tanaka Yoshiya, Takeuchi Tsutomu, Umehara Hisanori, Nanki Toshihiro, Yasuda Nobuyuki, Tago Fumitoshi, Kawakubo Makoto, Kitahara Yasumi, Hojo Seiichiro, Kawano Tetsu and Imai Toshio. 20180705. Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. : Modern rheumatology.

Harvard

Tanaka Y., Takeuchi T., Umehara H., Nanki T., Yasuda N., Tago F., Kawakubo M., Kitahara Y., Hojo S., Kawano T. and Imai T. (20180705). Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. : Modern rheumatology.

MLA

Tanaka Yoshiya, Takeuchi Tsutomu, Umehara Hisanori, Nanki Toshihiro, Yasuda Nobuyuki, Tago Fumitoshi, Kawakubo Makoto, Kitahara Yasumi, Hojo Seiichiro, Kawano Tetsu and Imai Toshio. Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis. : Modern rheumatology. 20180705.